天中依脉品牌怎么样 申请店铺

我要投票 天中依脉在医疗保健行业中的票数:879 更新时间:2025-08-15
公司简介: 天中依脉集团成立于2009年,现拥有三家全资子公司:天津市天中依脉科技开发有限公司、依脉人工智能医疗科技(天津)有限公司和汇汉依脉智能科技(上海)有限公司。公司坐落于天津滨海高新区华苑产业

外推网助力天中依脉品牌出海!将品牌入驻外推网,定制天中依脉品牌推广信息,可以显著提高天中依脉产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

天中依脉怎么样

公司简介:

天中依脉集团成立于2009年,现拥有三家全资子公司:天津市天中依脉科技开发有限公司、依脉人工智能医疗科技(天津)有限公司和汇汉依脉智能科技(上海)有限公司。公司坐落于天津滨海高新区华苑产业区,是我国专注于中医四诊客观化技术研究和中医诊疗设备的研发与制造的科技型国内知名高新企业之一。公司具有国内一流的中医诊疗仪器研发团队,完善的生产体系和检验设备,产品质量稳定可靠。公司的脉象仪,舌象仪等产品获得国家中医药管理局中医诊疗设备2011版第一批推荐品目。

天中依脉是较早专注于中医诊疗客观化的高新技术企业,核心技术脱胎于天津中医药大学、天津大学历届专家及从上世纪80年代开始的“中医客观化技术”研究。依脉人工智能医疗科技(天津)有限公司是天中依脉的全资子公司,致力于发展“中医云脑”智能化云中医服务,参与国家“一带一路”中医文化传播与技术推广,全面支持国家医联体建设、家庭医生签约服务等领域的中医药服务,践行健康中国战略。

 15625675637646365997938.png

2009年创立至今,天中依脉与国内三十余家高校及高级医疗机构建立了长期深入的科研合作关系,拥有200多项国家专利及软件著作等知识产权,产品服务于500余家医疗机构,成为中医智能行业的领航者。

公司荣誉:

●2009年,参与国家中医诊断仪器国际以及国家行业标准制定

●2009年,参与火星MARS500计划项目

●2011年,参与承担国家973项目

●2011年,舌象仪和脉象仪同时入选国家中医药管理局《中医诊疗设备推荐品目2011版第一批》

●2012年,参与国家自然基金项目

●2012年,参与国家十二五支撑项目

●2013年,获得中国科技部“科技型中小企业技术创新基金”

●2018年,天中依脉“智云中医”中医医联体管理、服务体系上市,并与全国多家中医机构建立合作关系。

公司愿景:

1、中医客观化诊疗技术,中医健康大数据和人工智能科技的国际领导品牌!

2、建立开放、共享、共赢的中医健康数据服务平台,打造中医健康产业生态群。

3、推动先进的中医科技和传统文化走向世界,服务全人类健康!

公司使命:

创新中医科技,传承中医文化,引领健康生活!

Company profile: Tianzhong Yimai group, founded in 2009, now has three wholly-owned subsidiaries: Tianjin Tianzhong Yimai Technology Development Co., Ltd., Yimai artificial intelligence medical technology (Tianjin) Co., Ltd. and Huihan Yimai Intelligent Technology (Shanghai) Co., Ltd. The company is located in Huayuan Industrial Zone, Binhai high tech Zone, Tianjin. It is one of the well-known high-tech enterprises in China, which focuses on the research and development and manufacturing of the four diagnosis and treatment objectification technology of traditional Chinese medicine and the diagnosis and treatment equipment of traditional Chinese medicine. The company has a domestic first-class R & D team of TCM diagnosis and treatment instruments, perfect production system and testing equipment, and stable and reliable product quality. The company's pulse instrument, tongue instrument and other products have won the first batch of recommended items of Chinese medicine diagnosis and treatment equipment 2011 edition of the State Administration of traditional Chinese medicine. Tianzhong Yimai is an early high-tech enterprise focusing on the objectification of TCM diagnosis and treatment. Its core technology was born from the experts of Tianjin University of traditional Chinese medicine, Tianjin University and the research on "objectification technology of TCM" since the 1980s. One belt, one road, China's Tianjin medical company (China) is a wholly-owned subsidiary of the Chinese medicine company. It is committed to the development of the "Yun Nao" intelligent Chinese medicine service, participating in the "one belt and one way" Chinese medicine culture dissemination and technology promotion, and fully supporting the traditional Chinese medicine service in the fields of national medical conjoined construction, family doctor's contract service and so on, and practicing the healthy China strategy. Since its establishment in 2009, Tianzhong Yimai has established a long-term and in-depth scientific research cooperation relationship with more than 30 universities and advanced medical institutions in China. It has more than 200 national patents and software works and other intellectual property rights. Its products serve more than 500 medical institutions and become a leader in the intelligent industry of traditional Chinese medicine. Honors of the company: ● in 2009, participated in the development of international and national industry standards for diagnostic instruments of traditional Chinese medicine ● in 2009, participated in Mars Mars 500 program project ● in 2011, participated in the national 973 project ● in 2011, tongue imager and pulse imager were selected into the first batch of recommended items of Chinese medical diagnosis and treatment equipment 2011 edition by the State Administration of traditional Chinese medicine ● in 2012, participated in the national natural fund project ● 201 2 years, participated in the national 12th Five Year Plan support project ● in 2013, won the "technology innovation fund for small and medium-sized enterprises of science and technology type" of the Ministry of science and technology of China ● in 2018, Tianzhong Yimai "Zhiyun TCM" TCM management and service system went public, and established cooperation with many TCM institutions across the country. Company vision: 1. Objective diagnosis and treatment technology of traditional Chinese medicine, international leading brand of health big data and artificial intelligence technology of traditional Chinese medicine! 2. Establish an open, shared and win-win TCM health data service platform, and build an ecosystem of TCM health industry. 3. Promote the advanced technology of traditional Chinese medicine and traditional culture to the world, and serve the health of all mankind! Mission of the company: innovate TCM technology, inherit TCM culture and lead healthy life!

本文链接: https://brand.waitui.com/93449407c.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

机构:预估全年LED照明市场规模将下滑至535.73亿美金

36氪获悉,根据TrendForce集邦咨询最新报告《2025全球LED照明市场趋势--数据资料库与厂商策略-2H25》分析指出,近期国际形势的变化加剧了全球经济环境的不确定性,企业投资与商业活动明显收缩。LED高光效、人因健康照明、智慧照明和循环照明产品在2025年上半年(1H25)订单表现十分亮眼,成为部分终端照明厂商营收贡献及稳固市场份额的关键动力。TrendForce预估全年LED照明市场规模将下滑4.4%至535.73亿美金。

10分钟前

摩根士丹利:苹果公司已度过关税风险,股价可能还有更大上涨空间

摩根士丹利表示,苹果公司的股价近期呈上涨趋势,可能还有更大的上涨空间。分析师埃里克・伍德林写道:“我们正变得更加乐观,并且认为苹果的情况可能即将出现转机。”该公司提到了iPhone的积极发展趋势、苹果的定价能力,并认为 “我们已度过关税风险的高峰期”,同时 “监管因素并非如担忧的那样构成重大的短期阻力”。(新浪财经)

10分钟前

王兴兴:明年一定参加北京亦庄半程马拉松暨人形机器人半程马拉松

据贝壳财经,8月15日下午,宇树在2025世界人形机器人运动会开赛首日摘得1500米、400米赛跑冠军。宇树科技创始人、CEO王兴兴表示,明年一定会参加在亦庄举行的北京亦庄半程马拉松暨人形机器人半程马拉松,下一次比赛时机器人选手将全自主奔跑。(新浪财经)

10分钟前

李强:扎实推动产业绿色低碳转型,加快形成科技含量高、资源消耗低、环境污染少的产业结构

中共中央政治局常委、国务院总理李强出席2025年全国生态日主场活动开幕式暨践行绿水青山就是金山银山理念座谈会。李强指出,我国经济社会发展已进入加快绿色化、低碳化的高质量发展阶段,必须坚定不移走生态优先、绿色发展之路。要以更大力度把绿水青山建得更美,持续深入打好污染防治攻坚战,着力提升生态系统多样性、稳定性、持续性,切实筑牢国家生态安全屏障。要以绿色发展方式把金山银山做得更大,持续优化国土空间开发保护格局,扎实推动产业绿色低碳转型,加快形成科技含量高、资源消耗低、环境污染少的产业结构。(新华社)

10分钟前

深圳机场:上半年净利润3.12亿元,同比增长79.13%

36氪获悉,深圳机场公告,公司上半年实现营收25.28亿元,同比增长12.32%;归属于上市公司股东的净利润为3.12亿元,同比增长79.13%。

10分钟前

本页详细列出关于天中依脉的品牌信息,含品牌所属公司介绍,天中依脉所处行业的品牌地位及优势。
咨询